Bepirovirsen is an effective antiviral drug for the treatment of chronic hepatitis B.
Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.
Innovative Medicago’s vaccine is made by molecular pharming technology.
Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.
Molecular Partners and Novartis believe in the success of DARPins.